Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Gefitinib|DRUG: Tamoxifen
Sponsor: AstraZeneca